APIMEDS PHARMACEUTICALS US, INC. Deferred Tax Assets, Operating Loss Carryforwards
APIMEDS PHARMACEUTICALS US, INC. (APUS) had Deferred Tax Assets, Operating Loss Carryforwards of $2.47 million as of 2025-12-31, per its 10-K filed 2026-05-04.
Financial Statements › Notes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross › Deferred Tax Assets, Operating Loss Carryforwards, Components
us-gaap:DeferredTaxAssetsOperatingLossCarryforwards · last filed 2026-05-04
- 2025-12-31: Deferred Tax Assets, Operating Loss Carryforwards $2.47M.
- 2024-12-31: Deferred Tax Assets, Operating Loss Carryforwards $741.32K.
- 2023-12-31: Deferred Tax Assets, Operating Loss Carryforwards $537.88K.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards |
|---|---|
| 2025-12-31 | $2.47M 10-K · filed 2026-05-04 |
| 2024-12-31 | $741.32K 10-K · filed 2026-05-04 |
| 2023-12-31 | $537.88K 10-K · filed 2025-04-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |